Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jul 10;32(2):315–331. doi: 10.1016/j.pnpbp.2007.07.001

Figure 2.

Figure 2

PET FDG measurement of brain metabolism before and after treatment with isotretinoin. There is a visible decrease in function of the orbitofrontal cortex in this representative patient after four months of treatment with isotretinoin. This patient developed headache and subtle behavioral changes, but not clinical depression.